Clinical Services

Novavax vaccine demonstrates 89.3% efficacy

03 February, 2021

Novavax has announced that its protein-based COVID-19 vaccine candidate has demonstrated a vaccine efficacy of 89.3% in a Phase 3 clinical trial conducted in the UK.


Whiteley Viraclean hospital-grade disinfectant

01 February, 2021 | Supplied by: Whiteley

Viraclean from Whiteley is a hospital-grade, hard surface disinfectant proven to kill a wide range of bacteria and viruses, including SARS-CoV-2 (the virus that causes COVID-19).


COVID-19 may reduce male fertility

01 February, 2021

A German study indicates that COVID-19 infection can cause increased sperm cell death, inflammation and oxidative stress, resulting in lower sperm quality and potentially reducing fertility.


Monash innovation reduces risk of COVID in healthcare workers

29 January, 2021

A Monash University study reveals that a simple ventilated headboard hood can stop SARS-CoV-2 from spreading between patients and healthcare workers on hospital wards.


Hospital pharmacists prepare for vaccine rollout

27 January, 2021

With COVID-19 vaccinations set to roll out in less than one month, Australia's hospital pharmacists are preparing for their central role in the administration process.


Study predicts global cancer surgery surge

27 January, 2021

A modelling study led by UNSW Sydney predicts that global demand for cancer surgery will rise by 52% within two decades, with low-income countries bearing the greatest burden.


Immunotherapy trial holds hope for children needing stem cell transplants

26 January, 2021

A new immunotherapy treatment will be studied in clinical trials, with the aim of preventing dangerous side effects for children who have to undergo stem cell transplants.


TGA approves Pfizer/BioNTech vaccine

25 January, 2021

The Australian Therapeutic Goods Administration (TGA) has provisionally approved the Pfizer/BioNTech COVID-19 mRNA vaccine, COMIRNATY.


How soon will we reach herd immunity for COVID-19?

25 January, 2021 by Amy Sarcevic

Achieving herd immunity for COVID-19 may be a challenge through current vaccination programs, research from the Imperial College London has found.


Predicting risk of spinal fracture using bioengineering

22 January, 2021 by Assistant Professor Dennis E Anderson, Brett Allaire, Dr Hossein Mokhtarzadeh and Professor Mary L Bouxsein

Researchers have developed biomechanical models that use mathematical- and physics-based representations of human movement to predict spinal loading.


UniSA test accurately predicts mood disorders

21 January, 2021

Based on levels of a specific protein found in the brain, the test is reported to be the first of its kind in the world.


REDFEB highlights how to recognise and handle a heart attack

21 January, 2021

Heart Research Australia is encouraging Australians to wear red and donate during February, to raise awareness for heart disease and funds for life-saving research.


New mammogram measures for assessing breast cancer risk

20 January, 2021

An international team of researchers, led by The University of Melbourne, has found two new mammogram-based measures for breast cancer risk.


The potential of androgens in breast cancer treatment

19 January, 2021

An international study has uncovered new evidence of the positive role of androgens in breast cancer treatment.


GPs to take lead role in COVID-19 vaccine rollout

14 January, 2021

The RACGP has welcomed government confirmation that GPs will be at the forefront of Australia's COVID-19 vaccine rollout.


  • All content Copyright © 2021 Westwick-Farrow Pty Ltd